pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
Endpoints·May 28·1 min read
save

Oura expands into health services with launch of smaller Ring 5 wearable

May 28, 2026·read at Endpoints ↗Positive

Oura announced the release of its new Ring 5, a smaller version of its popular health‑tracking ring.

Alongside the hardware launch, the company said it will add features that let users link their personal health records to the ring’s data.

Oura also plans to work with medical providers to turn the ring’s insights into actionable care recommendations.

The move signals Oura’s shift from a pure consumer‑focused device toward a broader role in digital health services.

source

This writeup was produced by pharmadog from original reporting by Endpoints.

Original headline: “Oura pushes deeper into healthcare services as part of new ring launch”

read at Endpoints ↗
91 words · retrieved Jun 3
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

no entities indexed yet

related stories

  • 1h agoVanda’s social anxiety drug flunks Phase 3 trial in female patientsEndpoints
  • 1h agoPaul Stoffels to bring Galapagos’ cell therapies back to lifeEndpoints
  • 4h agoIambic snags $150M IPO for AI-driven cancer pipelineEndpoints
  • 6h agoOMass Therapeutics collects $310M to chase Neurocrine, Vertex in genetic adrenal disorderEndpoints
  • 17h agoSanofi's new R&D chief: Western pharma should rethink China's drug pipeline roleEndpoints